Patent extenders stretch drugmakers' bottom lines Sep 10, 2006
Since a generic of Abbott Laboratories' Biaxin known as clarithromycin came on the market last year, the twice-a-day copy has eaten into once-a-day Biaxin XL ... -Chicago Tribune
Colchicine toxicity with concomitant use of Clarithromycin Sep 16, 2006
There have been post-marketing reports of Colchicine toxicity with concomitant use of Clarithromycin ( Biaxin/Klacid ) and Colchicine, especially in the elderly ... -Xagena.it
A PINCH OF SALT IS MORE THAN ENOUGH Aug 26, 2006
Biaxin is an antibiotic that does this for me. ... I don't understand why Biaxin works and Zithromax doesn't. They're closely related compounds. ... -Charlotte Sun-Herald
ABBOTT LABORATORIES: Reaches settlement over Biaxin lawsuit Aug 2, 2006
Ltd., the world's biggest generic-drug company, and North Chicago-based Abbott Laboratories agreed to settle a patent lawsuit over the antibiotic Biaxin XL on ... -Chicago Tribune
Abbott Labs, Teva Pharma Settle Biaxin XL Patent Dispute Aug 1, 2006
Abbott Laboratories (ABT) said Tuesday that Teva Pharmaceuticals Industries (TEVA) agreed to settle a patent lawsuit involving Abbott's antibiotic Biaxin XL. ... -Easy Bourse (Communiqués de presse)
A PINCH OF SALT IS MORE THAN ENOUGH Aug 26, 2006
Biaxin is an antibiotic that does this for me. ... I don't understand why Biaxin works and Zithromax doesn't. They're closely related compounds. ... -Charlotte Sun-Herald
Multiple Medication Use in General Practice and Psychiatry: So ... Aug 23, 2006
Pimozide (Orap) is partly metabolized through CYP3A and clarithromycin (Biaxin) substantially inhibits this enzyme, resulting in serious cardiotoxicity. ... -Psychiatric Times
John Spetrino Named Chief Creative Officer at Flashpoint Medica Aug 23, 2006
...that Spetrino's track record includes the blockbuster launches of Avandia (rosiglitazone), Yasmin (drospirenone/ethinyl estradiol) and Biaxin (clarithromycin). ... -Yahoo! News
CVS Q2 2006 Earnings Conference Call Transcript (CVS) Aug 3, 2006
In the third quarter thus far we have seen a few significant introductions, including generic versions of Zithromax Suspension, Biaxin and Mobic. ... -Seeking Alpha
Health Briefs: Avian flu is topic Jul 30, 2006
Network of the National Institutes of Health/National Heart, Lung, and Blood Institute to determine if clarithromycin (trade name Biaxin), an antibiotic, will ... -North County Times
For the Health of It Jul 30, 2006
In the first, researchers will ascertain whether prolonged use of the antibiotic clarithromycin (trade name: Biaxin) can ease the symptoms of asthma. ... -North County Times
Immtech Appoints Carol Ann Olson, MD to Senior Vice President of ... Jul 25, 2006
In that role, she was responsible for clinical development of antibiotics for outpatient respiratory tract infections, including clarithromycin (Biaxin(R)) and ... -PR Newswire
US court lifts injunction in Biaxin patent case Jun 22, 2006
TEVA.TA: Quote, Profile, Research) of its generic version of Abbott Laboratories Inc.'s (ABT.N: Quote, Profile, Research) extended-release antibiotic Biaxin. ... -Reuters
UPDATE 1-Teva says to stop sales of generic Biaxin XL Jun 27, 2006
...(ABT.N: Quote, Profile, Research) has filed an emergency motion in US federal court to try to block sales of a generic version of Abbott's Biaxin XL. ... -Reuters
Preliminary ban voided on generic Biaxin Jun 23, 2006
...maker Teva Pharmaceuticals Industries Ltd. from launching unauthorized copies of Abbott Laboratories' Biaxin XL. The US Court of ... -Chicago Tribune
Abbott Moves to Block Biaxin Sales Jun 27, 2006
...pharmaceutical company, said Tuesday that Abbott Laboratories filed an emergency motion to stop Teva from further sales of its generic Biaxin XL Filmtabs. ... -TheStreet.com
UPDATE 2-Teva wins round in Biaxin patent case Jun 22, 2006
...an injunction against its sale of the generic version of Abbott Laboratories Inc.'s (ABT.N: Quote, Profile, Research) extended-release antibiotic Biaxin. ... -Reuters
Abbott tries to halt Teva’s generic Biaxin sales Jun 28, 2006
...(NYSE:MRK) over Zocor, the US Court of Appeals for the Federal Circuit ruled in favor of Teva, allowing the company to market generic Biaxin. ... -Globes
US court lifts injunction in Abbott's Biaxin patent case Jun 22, 2006
Pharmaceutical Industries Ltd., lifting an injunction against its sale of the generic version of Abbott Laboratories Inc.'s extended-release antibiotic Biaxin. ... -Crain's Chicago Business
Teva Launches Generic Biaxin; To Refrain From Sales Pending ... Jun 27, 2006
...(TEVA | charts | news | PowerRating), a generic pharmaceutical company, said on Tuesday that it launched its generic Biaxin or Clarithromycin XL Filmtabs on ... -Trading Markets
Teva Provides Generic Biaxin(R) XL Update Jun 27, 2006
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it launched Teva's generic Biaxin(R) (Clarithromycin) XL Filmtabs(R) last Friday ... -International News Service
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL ... Jun 22, 2006
Court for the Northern District of Illinois, which had granted Abbott's motion for a preliminary injunction related to Teva's generic Biaxin(R) (Clarithromycin ... -Genetic Engineering News
Teva Agrees To Refrain From Further Sales Of Generic Biaxin XL ... Jun 27, 2006
...(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA | charts | news | PowerRating) said Tuesday that it launched Teva's generic Biaxin XL Filmtabs last ... -Trading Markets
Teva pulls generic Biaxin after Abbott files lawsuit Jun 28, 2006
Teva launched a generic version of Abbott's Biaxin XL product last Friday, after a federal court of appeal overturned a preliminary injunction blocking its ... -Pharma Times (subscription)
Teva Provides Generic Biaxin(R) XL Update Jun 27, 2006
...(Nasdaq: TEVA) announced today that it launched Teva's generic Biaxin(R) (Clarithromycin) XL Filmtabs(R) last Friday following the decision rendered on ... -Business Wire
UPDATE - Teva Pharmaceutical (TEVA) Issues Press Release Regarding ... Jun 22, 2006
...for the Northern District of Illinois, which had granted Abbott's (NYSE: ABT) motion for a preliminary injunction related to Teva's generic Biaxin XL Filmtabs. ... -StreetInsider.com (subscription)
Teva Says Court Rules In Its Favor In Biaxin Injunction Jun 22, 2006
...district court ruling which had granted Abbott Laboratories' (ABT) motion for a preliminary injunction related to Teva's generic version of Biaxin XL filmtabs. ... -Therapeutics Daily (subscription)
Abbott Announces Strong Second-Quarter Results and Raises Full ... Jul 19, 2006
18.6 Kaletra $118 23.5 $147 5.0 (b) $265 12.5 TriCor $251 14.7 --- -- $251 14.7 Ultane/Sevorane $65 (23.2) $143 1.2 (c) $208 (7.9) Biaxin (clarithromycin) $29 ... -Yahoo! News
Teva halts sales of generic antibiotic Jun 27, 2006
Drugmaker stops sales of Biaxin XL until court rules on patent protection of Abbott drug. Teva halts sales of antibiotic pending ... -CNNMoney.com
Court lifts injunction against Teva drug Jun 22, 2006
Appeals court finds little merit in rival Abbott's patent infringement case over respiratory and skin infection drug Biaxin. WASHINGTON ... -CNNMoney.com
Teva Pharma Says US Appeal Court Vacates Injection Barring Sale Of ... Jun 22, 2006
Earlier in June Illinois District court had granted a preliminary injection barring the sale of Teva's generic Biaxin or Clarithromycin extended release ... -Trading Markets
Teva halts sales of antibiotic pending hearing Jun 27, 2006
Teva said it agreed to stop selling its version of the extended release antibiotic Biaxin XL pending outcome of a hearing set for Thursday before the judge who ... -MSN Money
Teva Pharma Says Court Of Appeals Rules In Favor Of Company On ... Jun 22, 2006
...ruling from the US Court of Appeals for the Federal Circuit regarding Abbott's motion for a preliminary injunction related to Teva's generic Biaxin XL Filmtabs ... -Trading Markets
Having cat in house may increase risk of eczema Jul 18, 2006
SSRI drugs can trigger serotonin syndrome in combination with a number of other drugs, ranging from antibiotics like Biaxin to pain medicine like tramadol ... -Jackson Clarion Ledger
Multiple Myeloma Oral Therapy REVLIMID Approved By FDA Jul 17, 2006
...to offer a research protocol using a chemotherapy cocktail with REVLIMID, known as BiRD, an acronym for its component parts: Biaxin® (clarithromycin, an ... -Medical News Today
Teva agrees temporary halt of generic antibiotic sale after Abbott ... Jun 27, 2006
Abbott's motion for a preliminary injunction related to Teva's drug, which is the generic equivalent of Abbott's Biaxin XL Filmtabs. ... -Forbes
Israeli shares continue drop in Wed. morning trade Jun 28, 2006
...decliner, down 2.82%, while Teva Pharmaceutical Industries was also lower after the drug company said it would halt sales of generic Biaxin pending a court ... -Jerusalem Post
The Generic Onslaught Jun 23, 2006
...will have expired on 16 drugs--including allergy pill Allegra and cholesterol pill Pravachol, which have already expired, and Flonase and Biaxin, which could ... -Forbes
Thursday's Health Winners & Losers Jun 29, 2006
...drug Zocor and an ongoing patent infringement battle with Abbott (ABT:NYSE - commentary - Cramer's Take) over a generic version of the antibiotic Biaxin. ... -TheStreet.com
Appeals Court Vacates Teva Injunction Jun 22, 2006
Laboratories a preliminary injunction against Teva's Clarithromycin Extended Release Tablets, which are a generic equivalent of Abbott's Biaxin XL Filmtabs. ... -Houston Chronicle
Wed: Gaza on TASE’s mind Jun 28, 2006
Abbot Laboratories (NYSE: ABT) announced it would file a further appeal in the US courts to block the launch by Teva of a generic version of the drug Biaxin. ... -Globes
Teva chief: Generic Zocor launch a success Jun 28, 2006
Last Friday, Teva also launched generic Biaxin (Clarithromycin), but on Monday, Abbott Laboratories (NYSE: ABT) filed an emergency motion in the US District ... -Globes
Category: Fairway Woods Jul 5, 2006
Phentermine quick Fahrenheit pills [url]http://phentermineec.greatnow.com/fahrenheit-pills.html[/url] [url]http://valiumec.usafreespace.com/biaxin-online.html ... -Golf-Gear-Review.com
Abbott Labs 1Q profit rises 3 percent Apr 19, 2006
...treatment Humira rose 39 percent to $392 million and sales of HIV drug Kaletra grew by 18 percent to $280 million, while sales of the antibiotic Biaxin fell 30 ... - BusinessWeek
Fitch Rates Abbott's $4B Senior Notes 'AA-' May 10, 2006
31, 2006, supported by strong growth of Humira offset by generic competition for Synthroid and the immediate-release formulation of Biaxin and restructuring of ... - Business Wire
Abbott Labs First-Quarter Profit Up 3 Pct. Apr 19, 2006
Humira rose 39 percent to $392 million and sales of HIV HIV drug Kaletra grew by 18 percent to $280 million, while sales of the antibiotic Biaxin fell 30 ... - The Westfall Weekly News
Abbott Reports First Quarter Results Led by Strong Medical ... Apr 19, 2006
1Q05 Pharmaceutical Products HUMIRA $218 33.2 $174 46.9 (a) $392 38.9 Kaletra $120 27.6 $160 11.3 (b) $280 17.7 Biaxin (clarithromycin) $51 (55.2) $198 (17.3)(c ... - PR Newswire
Bristol-Myers Squibb Hangs No Sale Sign on Tequin May 2, 2006
...more likely to develop hypoglycemia and 17 times more likely to be hospitalized for hyperglycemia than similar patients treated with Biaxin (clarithromycin) or ... - MedPage Today
Abbott Labs first-quarter profit up 3 pct. Apr 19, 2006
But sales of the antibiotic Biaxin fell 30 percent to $249 million, a decline Abbott blamed on generic competition and a weaker flu season. ... - BusinessWeek
Abbott net up as better margins offset sales slip Apr 19, 2006
Growth in US pharmaceutical sales was partially offset by a decline in sales of the antibiotic Biaxin, as generic competition and a weaker flu season took its ... - Reuters
Strong Humira sales help lift Abbott to 3.2% gain Apr 19, 2006
But worldwide sales of Abbott's once big-selling Biaxin antibiotic, which lost US patent protection last year, dropped 30 percent, to $249 billion. ... - Chicago Tribune
Abbott Q1 Profit Up 3.2%, Sales Misses Street's View; Backs Full ... Apr 19, 2006
Growth in US pharmaceuticals was partially offset by a decline in Biaxin sales resulting from the May 2005 entrance of generic competition for the immediate ... - Trading Markets
Report any muscle issues while using statin drugs Mar 27, 2006
Q: An ENT doctor prescribed an antibiotic called Biaxin XL. ... A: Biaxin "XL" is an extended-release form of Biaxin (clarithromycin). ... - Contra Costa Times
Earnings decline at Andrx for Q4, year Mar 18, 2006
The most recent quarter included a $5.6 million charge on inventory because Andrx has not yet been able to launch its regulator-approved generic for Biaxin XL. ... - Bizjournals.com
Andrx 4Q Profit Slides 60 Percent Mar 16, 2006
The quarter was hurt by a $5.6 million inventory charge due to the delayed launch of Andrx's generic version of the antibiotic Biaxin XL. ... - MSN Money
Andrx Corporation Reports Financial Results for 2005 Fourth ... Mar 16, 2006
...quarter, Abbott Laboratories was granted a preliminary injunction pending a trial on the merits related to our FDA-approved generic version of Biaxin(R) XL ... - Business Wire
Abbott vital signs strong as devices infuse profits Mar 13, 2006
Abbott, too, was hit last year by the loss of patent protection on its once top-selling antibiotic Biaxin, and in 2008 its $1 billion-a-year bipolar disorder ... - Chicago Tribune
UPDATE 1-Andrx posts lower quarterly earnings as revs fall Mar 16, 2006
...(ABT.N: Quote, Profile, Research) prevented Andrx's planned fourth-quarter launch of a generic version of Biaxin XL antibiotic, resulting in a $5.6 million ... - Reuters
Andrx Q4 Net Income More Than Halves -update Mar 16, 2006
...charts | news | Powerrating) was granted a preliminary injunction pending a trial on the merits related to our FDA-approved generic version of Biaxin XL, which ... - Trading Markets
Tequin Linked to High Risk of Dangerous Glucose Changes Mar 1, 2006
...more likely to develop hypoglycemia and 17 times more likely to be hospitalized for hyperglycemia than similar patients treated with Biaxin (clarithromycin) or ... - MedPage Today,
Abbott Reports Record Sales, Earnings and Cash Flow in 2005 Jan 25, 2006
66.1 $159 54.6 $441 61.8 Depakote $334 9.9 $16 26.1 $350 10.6 TriCor $312 37.5 --- -- $312 37.5 Mobic $306 18.4 --- -- $306 18.4 Biaxin (clarithromycin) $93 ... - MSN Money
Earnings Preview: Abbott Laboratories Jan 24, 2006
SG Cowen's Sara Michelmore noted that the company is facing generic competition for its Ultane anesthetic and Biaxin antibiotic, but said much of this risk is ... - BusinessWeek
Abbott shares rise on Q4 and Guidant win Jan 26, 2006
On the down side, Biaxin (clarithromycin) revenues dropped 26.4% to $281 million, as immediate-release versions of the drug are subjected to mounting generic ... - Pharma Times (subscription)
Fitch: Abbott Laboratories' Ratings Unchanged After Acquisition ... Jan 9, 2006
30, 2005, supported by attractive growth of Humira, offset by generic competition for Synthroid and the immediate-release formulation of Biaxin. - Business Wire